The Treatment of Myelomatosis with Lutecium 177

Abstract
Three patients with myelomatosis were given intravenous Lu177. The Lu177 was shown to be taken up by the bones and concentrated around the lesions. None of the patients was clinically improved by treatment with this isotope.